Literature DB >> 20375636

Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation.

Nathalie Koning1, Marco van Eijk, Walter Pouwels, Michael S M Brouwer, David Voehringer, Inge Huitinga, Robert M Hoek, Geert Raes, Jörg Hamann.   

Abstract

Classical macrophage activation is inhibited by the CD200 receptor (CD200R). Here, we show that CD200R expression was specifically induced on human in vitro polarized macrophages of the alternatively activated M2a subtype, generated by incubation with IL-4 or IL-13. In mice, peritoneal M2 macrophages, elicited during infection with the parasites Taenia crassiceps or Trypanosoma brucei brucei, expressed increased CD200R levels compared to those derived from uninfected mice. However, in vitrostimulation of mouse peritoneal macrophages and T. crassiceps infection in IL-4-/- and IL-4R-/- mice showed that, in contrast to humans, induction of CD200R in mice was not IL-4 or IL-13 dependent. Our data identify CD200R as a suitable marker for alternatively activated macrophages in humans and corroborate observations of distinct species- and/or site-specific mechanisms regulating macrophage polarization in mouse and man.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20375636     DOI: 10.1159/000252803

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  46 in total

1.  Inhibitory receptor expression on neonatal immune cells.

Authors:  J Walk; G H A Westerlaken; N O van Uden; M E Belderbos; L Meyaard; L J Bont
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease.

Authors:  Megan M Varnum; Tomomi Kiyota; Kaitlin L Ingraham; Seiko Ikezu; Tsuneya Ikezu
Journal:  Neurobiol Aging       Date:  2015-08-01       Impact factor: 4.673

3.  Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction.

Authors:  Laura K Fonken; Matthew G Frank; Heather M D'Angelo; Jared D Heinze; Linda R Watkins; Christopher A Lowry; Steven F Maier
Journal:  Neurobiol Aging       Date:  2018-07-24       Impact factor: 4.673

4.  Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells.

Authors:  Jing Wang; Yuko Shirota; Defne Bayik; Hidekazu Shirota; Debra Tross; James L Gulley; Lauren V Wood; Jay A Berzofsky; Dennis M Klinman
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

5.  Deciphering the pathways of death of Histoplasma capsulatum-infected macrophages: implications for the immunopathogenesis of early infection.

Authors:  George S Deepe; William R Buesing
Journal:  J Immunol       Date:  2011-11-18       Impact factor: 5.422

6.  Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.

Authors:  Young-June Kim; Su-Jung Park; Hal E Broxmeyer
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

Review 7.  The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.

Authors:  Megan M Varnum; Tsuneya Ikezu
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-06-19       Impact factor: 4.291

8.  Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand.

Authors:  Merav Cohen; Hila Ben-Yehuda; Ziv Porat; Catarina Raposo; Siamon Gordon; Michal Schwartz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

9.  Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Future Neurol       Date:  2013-05

Review 10.  IL-4 in the brain: a cytokine to remember.

Authors:  Sachin P Gadani; James C Cronk; Geoffrey T Norris; Jonathan Kipnis
Journal:  J Immunol       Date:  2012-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.